ftInvstr
KOPRAN · Healthcare ₹233.0 +0.86% Mkt Cap ₹1129 Cr overvalued

KOPRAN

Healthcare Drug Manufacturers - General
₹233.0
+0.86% today · 30d +21.99%
as of 2026-09-04
Price · Daily Candles
AI narrative is temporarily unavailable for KOPRAN. The deterministic sections below render from live data.
₹ Latest Earnings · Q ending 2026-06-30
REVENUE
₹154 Cr
+13.89% YoY
NET PROFIT
₹7 Cr
-10.05% YoY
OPM
11.44%
-0.67pp YoY
EPS
₹1.39
PE 47.37
Intrinsic value · DCF ₹69.86 · Margin of safety -70.0% (overvalued) · FCF yield 0.73%
◇ Sector Position
PEERPEROCE %
KOPRAN47.377.0
GLAXO46.8657.97
RUBICON101.0127.36
PFIZER28.6424.29
+ 2 more peers — sign in to view
ML Forward Growth Predictions 🔒

9 ML-predicted forward-growth ranks across sales, EBIT, and FCF.

Sign up freeSign in
63
SCORE / 100
Overall
6-axis composite of the sections below.
Performance STRONG 100
Valuation FAIR 40
Growth MUTED 39
Profitability AVERAGE 42
Technicals NEUTRAL 65
Risk LOW 90
Key Stats
TTM PE
47.37
P/B
2.24
52W HIGH
₹242.8
OFF HIGH
-4.04%
DIV YIELD
1.29%
MKT CAP
₹1129 Cr
◉ Active Signals
MACDBullish4.1618
RSI(14)Bearish73.64
Near 52W HighBullish-4.04
⧉ Strategy Fit 🔒

See which of ftInvstr's 50+ strategies hold KOPRAN and at what entry.

Sign up freeSign in